Cutler Group LP Myriad Genetics Inc Call Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2018 Aug 10, 2018	SELL	$27.75 - $40.17 $604,950 - $875,706	-21,800 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$28.83 - $41.01 $276,768 - $393,696	9,600 Added 78.69%	21,800 $20,000
Q4 2017 Jan 17, 2018	BUY	$28.45 - $37.14 $321,485 - $419,682	11,300 Added 1255.56%	12,200 $53,000
Q3 2017 Oct 17, 2017	BUY	$24.01 - $36.2 $21,609 - $32,580	900	900 $3,000

250

90.6M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $999M
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.